Protective effect of ssanghwa-tang fermented by lactobacillus fermentum against carbon tetrachloride-induced acute hepatotoxicity in rats

African Journal of Traditional, Complementary and Alternative Medicines

Volumn 8, Issue 3, 2011, Pages 312-321

  Eum, Hyun Ae ^b   Lee, Ji Hye ^b   Yang, Min Cheol ^b   Shim, Ki Shuk ^b   Lee, Jae Hoon ^b   Ma, Jin Yeul ^a  

^a Korea Food Research Institute   (South Korea)

^b NONE

Author keywords

Carbon tetrachloride; Fermentation; Herbal fomula; Lactobacillus; Ssanghwa tang

Indexed keywords

ALANINE AMINOTRANSFERASE; ANGELICA GIGAS EXTRACT; ASPARTATE AMINOTRANSFERASE; ASTRAGALUS MEMBRANACEUS EXTRACT; CARBON TETRACHLORIDE; CINNAMON EXTRACT; CNIDIUM OFFICINALE EXTRACT; GINGER EXTRACT; GLYCYRRHIZA URALENSIS EXTRACT; HERBACEOUS AGENT; LACTATE DEHYDROGENASE; LIVER PROTECTIVE AGENT; PAEONIA LACTIFLORA EXTRACT; PLANT EXTRACT; REHMANNIA EXTRACT; SSANGHWA TANG; UNCLASSIFIED DRUG; ZIZYPHUS JUJUBE EXTRACT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CNIDIUM; CNIDIUM OFFICINALE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; FERMENTED PRODUCT; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; JUJUBE; LACTATE DEHYDROGENASE BLOOD LEVEL; LACTOBACILLUS CASEI; LACTOBACILLUS FERMENTUM; LACTOBACILLUS GASSERI; LIVER NECROSIS; LIVER PARENCHYMA; LIVER PROTECTION; MALE; NONHUMAN; RAT; TOXIC HEPATITIS; ZIZYPHUS JUJUBE;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BIOREACTORS; CARBON TETRACHLORIDE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG-INDUCED LIVER INJURY; L-LACTATE DEHYDROGENASE; LACTOBACILLUS FERMENTUM; LIVER; LIVER FUNCTION TESTS; MALE; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84863012257     PISSN: None     EISSN: 01896016     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ha, T.Y. and Park, D.I. (1998). Effect of ssanghwatang and ssanghwatang-mixed-paedokasan on the recovery of exercise induced fatigue. J. Life. Sci. 8: 366-372.
2. Ahn, B.N, Kim, S.K., Shim, C.K. and Chung, Y.B. (1984). Effects of a Chinese traditional medicine, ssang wha tang, on the pharmacokinetics of sulfobromophthalein in the rats of hepatic failure induced by carbon tetrachloride. Yakhak Hoeji 28: 207-215.
3. Han, Y.H. and Shim, C.K. (1989). Effects of a blended Korean herbal remedy, Ssang Wha Tang, on the liver cytoplasmic protein binding of sulfobromophthalein in rats. Phytother. Res. 3: 109-111.
4. Park, E.K., Choo, M.K., Yoon, H.K. and Kim, D.H. (2002). Antithrombotic and antiallergic activities of Rhaponticin from Rhei Rhizoma are activated by human intestinal bacteria. Arch. Pharm. Res. 25: 528-533.
5. Kim, D.H., Lee, K.T., Bae, E.A., Han, M.J. and Park, H.J. (1999). Metabolism of liriodendrin and syringin by human intestinal bacteria and their relation to in vitro cytotoxicity. Arch. Pharm. Res. 22: 30-34.
6. Kobashi, K. and Akao, T. (1997). Relation of intestinal bacteria to pharmacological effect of glycosides. Biosci. Microflora. 16: 1-7.
7. Kim, D.H., Yu, K.W., Bae, E.A., Park, H.J. and Choi, J.W. (1998). Metabolism of kalopanaxsaponin B and H by human intestinal bacteria and their antidiabetic activity of their metabolites. Biol. Pharm. Bull. 21: 360-365.
8. Hasegawa, H., Sung, J.W. and Benno, Y. (1997). Role of human intestinal Prevotella oris in hydrolyzing ginseng saponins. Planta Med. 63: 436-440.
9. Lee, D.S., Kim, Y.S., Ko, C.N., Cho, K.H., Bae, H.S., Lee, K.S., Kim, J.J., Park, E.K. and Kim, D.H. (2002). Fecal metabolic activities of herbal components to bioactive compounds. Arch. Pharm. Res. 25: 165-169
10. Hsiu, S.L., Lin, Y.T., Wen, K.C., Hou, Y.C. and Chao, P.D. (2003). A deglucosylated metabolite of paeoniflorin of the root of Paeonia lactiflora and its pharmacokinetics in rats. Planta Med. 69:1113-1118.
11. Heikal, O.A., Akao, T., Takeda, S. and Hattori, M. (1997). Pharmacokinetic study of paeonimetabolin I, a major metabolite of paeoniflorin from paeony roots. Bio. Pharm. Bull. 20: 517-521.
12. Takeda, S., Isono, T., Wakui, Y., Matsuzaki, Y., Sasaki, H., Amagaya, S. and Maruno, M. (1995). Absorption and excretion of paeoniflorin in rats. J. Pharm. Pharmacol. 47: 1036-1040.
13. He, J.X., Akao, T. and Tani, T. (2003) Restorative effect of repetitive administration of Shaoyao-Gancao-tang on bioavailability of paeoniflorin reduced by antibacterial synthetic drugs treatment in rats. Bio. Pharm. Bull. 26:1585-1590.
14. Sato, Y., He, J.X., Nagai, H., Tani, T. and Akao, T. (2007). Isoliquiritigenin, one of the antispasmodic principles of Glycyrrhiza ularensis roots, acts in the lower part of intestine. Bio. Pharm. Bull. 30:145-149.
15. Aroutcheva, A., Gariti, D., Simon, M., Shott, S., Faro, J., Simoes, J. A. and Faro S. (2001). Defense factors of vaginal lactobacilli. Am. J. Obstet. Gynecol. 185: 375-379.
16. Park, J. H., Lee, Y. H., Moon, E. P., Seok, S. H., Baek, M. W. and Lee, H. Y. (2005). Safety Assessment of Lactobacillus fermentum PL9005, a potential probiotic lactic acid bacterium, in mice. J. Microbiol. Biotechnol. 15(3): 603-608.
17. Klaenhammer, T. R. and Kullen, M. J. (1999). Selection and design of probiotics. Int. J. Food Microbiol. 50: 45-57.
18. Ingrassia, I., Leplingard, A. and Darfeuille-Michaud, A. (2005). Lactobacillus casei DN-114 001 inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn's disease patients to adhere to and to invade intestinal epithelial cells. Appl. Environ Microbiol. 71: 28880-28887.
19. Brink, M., Todorov, S.D., Martin, J.H., Senekal, M., and Dicks, L.M. (2006). The effect of prebiotics on production of antimicrobial compounds, resistance to growth at low pH and in the presence of bile, and adhesion of probiotic cells to intestinal mucus. J. Appl. Microbiol. 100(4):813-820.
20. Nemeth, E., Fajdiga, S., Malago, J., Koninkx, J., Tooten, P., and van Dijk, J. (2006). Inhibition of Salmonella-induced IL-8 synthesis and expression of Hsp70 in enterocyte-like Caco-2 cells after exposure to non-starter lactobacilli. Int. J. Food Microbiol. 112(3):266-274.
21. Isolauri, E., Juntunen, M., Rautanen, T., Sillanaukee, P., and Koivula, T. (1991). A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics. 88(1):90-97.
22. Srinivasan, R., Meyer, R., Padmanabhan, R. and Britto, J. (2006). Clinical safety of Lactobacillus casei shirota as a probiotic in critically ill children. J. Pediatr. Gastroenterol. Nutr. 42(2):171-173.
23. Yuan, R. and Lin, Y. (2000). Traditional Chinese medicine: an approach to scientific proof and clinical validation. Pharmacol. Ther. 86: 191-198.
24. Pyo, Y.H., Lee, T.C. and Lee, Y.C. (2005) Enrichment of bioactive isoflavones in soymilk. Food Res. International 38:551-559.
25. Gao, X., Qiao, S.Y. and Lu, W.Q. (2009). Determination of an economical medium for growth of Lactobacillus fermentum using response surface methodology. Lett. Appl. Microbiol. 49:556-561.
26. 4-induced hepatotoxicity in mice. Life Sci. 66:265-270.
27. 4 an adequate model of human cirrhosis? Hepatology 3: 112-120.
28. López-Novoa, J.M. and Rengel, M.A. (1977). A micropuncture study of salt and water retention in chronic experimental cirrhosis. Am. J. Physiol. 232: F315-F318.
29. 4-induced changes in liver microsomal P450 content and ethylmorphine metabolism. Life Sci. 7:129-136.
30. Athar, M., Zakir Hussain, S. and Hasan, N. (1997). Drug metabolizing enzymes in the liver. In: Rana, S.V.S., Taketa, K. (Eds.), Liver and Environmental Xenobiotics, Narosa Publishing House, New Delhi.
31. Bhat, V.B. and Madyastha, K.M. (2000). C-phycocyanin: a potent peroxyl radical scavenger in vivo and in vitro. Biochem. Biophys. Res. Commun. 275: 20-25.
32. Chang, Y.C. and Nair M.G. (1995). Metabolism of daidzein and genistein by intestinal bacteria. J. Nat. Prod. 58:1892-1896.
33. Setchell, K.D.R. and Cassidy, A. (1999). Dietary isoflavones: biological effects and relevance to human health. J. Nutr. 129:758S-767S.
34. Coward, L., Barnes, N.C., Setchell, K.D.R. and Barnes, S. (1993). Genistein, daidzein, and their b-glucoside conjugates: anti-tumor isoflavones in soybean foods from American and Asian diets. J. Agric. Food Chem. 41:1961-1967.
35. Choi, Y.B., Woo, J.G. and Noh, W.S. (1999). Hydrolysis of β-glucosidase bonds of isoflavone conjugates in the lactic acid fermentation of soymilk. Korean. J. Food. Sci. Technol. 31:189-195.
36. Tsangalis, D., Ashton, J.F., Stojanovska, L., Wilcox, G. and Shah, N.P. (2004). Development of an isoflavone aglycone-enriched soymilk using soy germ, soy protein isolate and bifidobacteria. Food Res. Int. 37:301-312.
37. Matsuda, S., Norimoto, F., Matsumoto, Y., Ohba, R., Teramoto, Y., Ohta, N. and Ueda, S. (1994). Solubilization of a novel isoflavone glucoside-hydrolyzing β-glucosidase from Lactobacillus casei. J. Ferment. Bioeng.77:439-441.
38. Kiyosawa, I., Matsuyama, J., Arai, C. and Setoguchi, T. (1995). Suppressive effects of the methanol extracts from soybean products on SOS response of Salmonella typhimurium induced by mutagens and their contents of isoflavones. Nippon Shokuhin. Kagaku. Kaishi 42: 835-842.